Disease | li-fraumeni syndrome |
Comorbidity | C0152013|lung adenocarcinoma |
Sentences | 1 |
PubMedID- 24169260 | Background: in lung adenocarcinoma, inactivation of the tumor suppressor p53 may abrogate a safeguard mechanism preventing the development of tumors with activating mutations in egfr or kras. |
Page: 1